HMS Veterinary Development

HMS Veterinary Development was a specialty pharmaceutical company focused on the development and commercialization of generic veterinary drugs, particularly topical and ophthalmic formulations for companion animals. Founded by Dr. Herbert M. Sarshik, the company successfully navigated the FDA's Abbreviated New Animal Drug Application (ANADA) process to bring several cost-effective alternatives to market, including generic versions of popular corticosteroid and antibiotic combinations. Their portfolio addressed common veterinary issues such as otitis externa and various dermatological infections in dogs and cats. Based in Coral Gables, Florida, the company was a pioneer in the generic animal health space during the 1980s and 1990s. The company's assets and product lines were eventually acquired by Med-Pharmex, which helped expand the availability of these essential veterinary treatments. Today, the products originally developed by HMS Veterinary Development continue to be marketed under the ownership of larger animal health corporations like Dechra Pharmaceuticals.